Evidence Update: Joint Pain and Aromatase Inhibitors
Joint Pain and Aromatase Inhibitors Aromatase inhibitors (AIs) have now been established as successful adjuvant therapy for breast cancer survivors who are post-menopausal and whose cancer is estrogen-receptor-positive. These include anastrozole (Arimidex), letrozole (Femara) and exemastane (Aromasin). Unfortunately, nearly half of women taking AIs report joint pain, or arthralgia. It is estimated that 20-30% of […]
Evidence Update: Pilates Based Exercise Beneficial
Pilates-Based Exercise Improves Upper Extremity Problems in Breast Cancer Patients It is well documented in the medical literature that breast cancer treatment, particularly surgery and radiation, contribute to upper extremity impairments, including decreased motion, weakness and difficulty doing usual functional tasks. A recent study examined the effectiveness of Pilates-based exercises, compared to combined exercise and home exercise as […]
Evidence Update: TurningPoint – Avon Breast Center at Grady Study Published
Hot off the press! This month’s evidence update features a study published this week by TurningPoint and our research partners at The Avon Breast Center at Grady Hospital and Emory University. The study examined the benefit of early identification and treatment of the physical side effects of breast cancer treatment, such as pain, limitation in […]
Evidence Update: Lymphedema At Risk Activities: Fact or Fiction?
Many of the precautionary guidelines related to lymphedema provided to breast cancer patients are anecdotal and not based on research. Unfortunately, many of these guidelines place a large burden on patients and clinicians who go to great lengths to abide by them. The avoidance behaviors can often be more impactful on quality of life than […]
